Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke

Sponsor
National Rehabilitation Center, Seoul, Korea (Other)
Overall Status
Unknown status
CT.gov ID
NCT03991364
Collaborator
(none)
20
1
2
18
1.1

Study Details

Study Description

Brief Summary

Comparison of the experimental group that applied the speed of the robot-assisted gait training constantly and the control group that applied the gradual increase of the speed of the robot-assisted gait training.

Condition or Disease Intervention/Treatment Phase
  • Other: Constant gait speed group
  • Other: Increasing gait speed group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke
Anticipated Study Start Date :
Jul 1, 2019
Anticipated Primary Completion Date :
Dec 31, 2020
Anticipated Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Constant gait speed group

experimental group that applied the speed of the robot-assisted gait training constantly

Other: Constant gait speed group
The speed of the robot-assisted gait treatment is constantly applied for 5 times a week for 2 weeks.

Other: Increasing gait speed group

control group that applied the gradual increase of the speed of the robot-assisted gait training

Other: Increasing gait speed group
The speed of the robot-assisted gait treatment is gradually increase for 5 times a week for 2 weeks.

Outcome Measures

Primary Outcome Measures

  1. Energy expenditure (EE) [2 weeks after baseline]

    EE(kcal/min): energy expenditure per minute

Secondary Outcome Measures

  1. Energy expenditure (EE) [baseline, 1 weeks after baseline, 3 weeks after baseline]

    EE(kcal/min): energy expenditure per minute

  2. Heart rate (HR) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]

    Cardiac frequency

  3. Volume of Oxygen (VO2) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]

    O2 consumption/1min

  4. Respiratory Quotient (R) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]

    Respiratory quotient

  5. Metabolic equivalent (METS) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]

    the amount of oxygen consumed while sitting at rest and is equal to 3.5 ml O2 per kg body weight x min

  6. oxygenated hemoglobin (OxyHb) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]

    oxygenated hemoglobin concentration of cortical activation

  7. deoxygenated hemoglobin (DeoxyHb) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]

    deoxygenated hemoglobin concentration of cortical activation

  8. Lower extremity Fugl-Meyer Assessment [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]

    Fugl-Meyer Assessment uses to examine the motor function and coordination of affected lower extremity. It includes 17 items of a 3-point ordinal scale, ranging 0-34, with higher scores indicating lower impairment.

  9. Functional Ambulation Category [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]

    Functional Ambulation Category is used to assess gait ability with 6 levels ranging from 0 to 5 on the basis of the amount of physical support required, regardless of use of an assistive device

  10. 10m walk test [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]

    10m walk test is used to examine gait speed, in which participant was asked to walk on a 14 meter of walkway wearing harness with two conditions; with the fastest speed or with self-selected comfortable speed.

  11. timed up and go test [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]

    simple test used to assess a person's mobility and requires both static and dynamic balance

Eligibility Criteria

Criteria

Ages Eligible for Study:
19 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hemiplegic patients secondary to first cerebrovascular accidents

  • Functional ambulation category score ≥ 3

Exclusion Criteria:
  • History of surgery of affected lower limb

  • Fracture of affected lower limb

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Rehabilitation Center Seoul Korea, Republic of 142884

Sponsors and Collaborators

  • National Rehabilitation Center, Seoul, Korea

Investigators

  • Principal Investigator: Joon-Ho Shin, MS, National Rehabilitation Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Joon-Ho Shin, Team manager, National Rehabilitation Center, Seoul, Korea
ClinicalTrials.gov Identifier:
NCT03991364
Other Study ID Numbers:
  • NRC-2019-01-002
First Posted:
Jun 19, 2019
Last Update Posted:
Jun 19, 2019
Last Verified:
Jun 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Joon-Ho Shin, Team manager, National Rehabilitation Center, Seoul, Korea
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 19, 2019